Wednesday, February 13, 2013 Tuesday, February 12, 2013 Monday, February 11, 2013- UCB and Amgen Abandon Trials for Fracture-Healing Drugat Motley Fool (Mon, Feb 11)
- Can Following The Insiders Into These Stocks Lead To Big Rewards?at Motley Fool (Mon, Feb 11)
- Amgen, UCB halt testing of fracture-healing drugAP (Mon, Feb 11)
- Has Amgen Become the Perfect Stock?at Motley Fool (Mon, Feb 11)
- Amgen: A Long-Term Growth Storyat Seeking Alpha (Mon, Feb 11)
- Jennerex liver cancer drug boosts immune system, quest for cashat bizjournals.com (Mon, Feb 11)
- 1 Powerhouse Drug in Celgene's Pipelineat Motley Fool (Mon, Feb 11)
- HIV/AIDS and Gilead Sciencesat Motley Fool (Mon, Feb 11)
- Stock Downgrades: Elan Losing Its Panacheat Minyanville (Mon, Feb 11)
Sunday, February 10, 2013 Friday, February 8, 2013Add AMGN News to My Yahoo!  | |
|